ScreenerHero

PAX Paxman AB (publ)

STO · SE · Healthcare · Medical Devices · paxmanscalpcooling.com
66.70SEK+0.76%Mkt Cap: 148.48M $P/E: —

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized for…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap148.48M USD
Enterprise Value138.45M USD
Revenue (TTM)35.00M USD
Gross Profit19.97M USD
Net Income (TTM)-1.60M USD
Revenue/Share14.91 SEK
Last Price66.70 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees151
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.15
PEG—
EV/EBITDA38.59
EV/Revenue3.96
P/S4.21
P/B3.70
EPS (TTM)-0.22
EPS (Forward)4.10
52W Range
41.0077% of range74.20
52W High74.20 SEK
52W Low41.00 SEK
Profitability
Gross Margin66.64%
Oper. Margin3.65%
EBITDA Margin10.25%
Profit Margin-5.33%
ROE-4.13%
ROA-3.49%
Growth
Revenue Growth40.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF706.58K USD
CapEx (TTM)2.25M USD
FCF Margin-8.67%
FCF Yield-2.04%
Net Debt-8.92M USD
Net Debt/EBITDA-2.49
Balance Sheet
Debt/Equity0.03
Current Ratio4.45
Quick Ratio3.75
Book Value/Sh17.91 SEK
Cash/Share4.54 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)95.75 SEK
Upside (mean)+43.6%
Target Range88.50 SEK – 103.00 SEK
88.50+43.6% to mean103.00
# Analysts2
Ownership
Shares Out.23.27M
Float16.62M
Insiders35.51%
Institutions24.53%
Technical
SMA 5054.58 (+22.2%)
SMA 20050.98 (+30.8%)
Beta0.48
S&P 52W Chg14.58%
Avg Vol (30d)29.71K
Avg Vol (10d)32.67K
Technical Indicators
RSI (14)76.8
MACD3.0189
MACD Signal2.6647
MACD Hist.+0.3542
BB Upper66.74 SEK
BB Middle61.05 SEK
BB Lower55.35 SEK
BB Width18.65%
ATR (14)1.829 SEK
Vol Ratio (20d)0.49x